Here are five insights:
1. JAZZ Lock is intended for degenerative spine disorder treatment.
2. The implant’s locking system does not require rod fixation, providing a shorter and simpler surgery.
3. Implanet’s Product Development & Manufacturing Director Régis Le Couedic commented most of the company’s future products will feature the unique locking mechanism.
4. Implanet has sold more than 300 JAZZ Lock implants since launching the product in the fall of 2016.
5. The company plans to release its 2016 financial results on March 28, 2017.
More articles on devices:
OrthAlign names Eric Timko new CEO and chairman of the board — 4 things to know
Alphatec Spine launches Arsenal Deformity Adolescent Idiopathic Scoliosis system: 5 notes
Globus releases quarterly earnings results — 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
